Forbes June 5, 2024
Topline
A Food and Drug Administration expert panel voted Wednesday to manufacture new COVID-19 vaccines to specifically target the JN.1 variant lineage—which makes up the most dominant strains circulating in the U.S.
Key Facts
Get Forbes Breaking News Text Alerts: We’re launching text message alerts so you’ll always know the biggest stories shaping the day’s headlines. Text “Alerts” to (201) 335-0739 or sign up here.
When Will Each Covid Vaccine Be Ready?
Each drugmaker gave different timelines for when their supplies will be ready. Bill Falstich, Pfizer’s vice president of global supply chain, primary care, said during the meeting his company’s vaccine will be ready immediately upon approval, and the company has “evaluated the expected demand… and we expect that...
Today's Sponsors
Today's Sponsor
